Article
Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
JAMA neurology - 1 Jul 2020
Belloy Michael E, Napolioni Valerio, Han Summer S, Le Guen Yann, Greicius Michael D
Abstract excerpt
Importance: Identification of genetic factors that interact with the apolipoprotein e4 (APOE4) allele to reduce risk for Alzheimer disease (AD) would accelerate the search for new AD drug targets. Klotho-VS heterozygosity (KL-VSHET+ status) protects against aging-associated phenotypes and cognitive decline, but whether it protects individuals who carry APOE4 from AD remains unclear. Objectives: To determine if...
Topics
Join the communities discussing this publication.
